(a) An individual or group health care service plan contract that is issued, amended, or renewed on or after January 1, 2020, shall not: (1) Deny a qualified enrolleeâs participation in an approved clinical trial. (2) Deny, limit, or impose additional conditions on the coverage of routine patient care costs for items and services furnished in connection with a qualified enrolleeâs participation in an approved clinical trial. (3) Discriminate against an enrollee based on the qualified enrolleeâs participation in an approved clinical trial. (b) (1) Subdivision (a) applies to: (A) A qualified enrollee participating in an approved clinical trial conducted by a participating provider. (B) A qualified enrollee participating in an approved clinical trial conducted by a nonparticipating provider, including a nonparticipating provider located outside this state, if the clinical trial is not offered or available through a participating provider. (2) If one or more participating providers is conducting an approved clinical trial, a health care service plan may require a qualified enrollee to participate in the clinical trial through a participating provider if the participating provider accepts the enrollee as a clinical trial participant. (3) A health care service plan may restrict coverage to an approved clinical trial in this state, unless the clinical trial is not offered or available through a participating provider in this state. (c) (1) The payment rate for routine patient care costs provided by a nonparticipating provider under a contract that is issued, amended, or renewed on or after January 1, 2020, shall be the negotiated rate the health care service plan would otherwise pay a participating provider for the same services, less applicable cost sharing. (2) Cost sharing for routine patient care costs shall be the same as that applied to the same services not delivered in a clinical trial, except that the in-network cost sharing and out-of-pocket maximum shall apply if the clinical trial is not offered or available through a participating provider. (3) This section does not limit or modify any existing requirements under this chapter or prevent application of cost-sharing provisions in a contract, except as provided in paragraph (2). (d) For purposes of this section: (1) âApproved clinical trialâ means a phase I, phase II, phase III, or phase IV clinical trial conducted in relation to the prevention, detection, or treatment of cancer or another life-threatening disease or condition that meets at least one of the following: (A) The study or investigation is approved or funded, which may include funding through in-kind donations, by one or more of the following: (i) The National Institutes of Health. (ii) The federal Centers for Disease Control and Prevention. (iii) The Agency for Healthcare Research and Quality. (iv) The federal Centers for Medicare and Medicaid Services. (v) A cooperative group or center of any of the entities described in clauses (i) to (iv), inclusive, the Department of Defense, or the United States Department of Veterans Affairs. (vi) A qualified nongovernmental research entity identified in the guidelines issued by the National Institutes of Health for center support grants. (vii) One of the following departments, if the study or investigation has been reviewed and approved through a system of peer review that the Secretary of the United States Department of Health and Human Services determines is comparable to the system of peer review used by the National Institutes of Health and ensures unbiased review of the highest scientific standards by qualified individuals who have no interest in the outcome of the review: (I) The United States Department of Veterans Affairs. (II) The United States Department of Defense. (III) The United States Department of Energy. (B) The study or investigation is conducted under an investigational new drug application reviewed by the United States Food and Drug Administ
‹ Prev All California sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.